Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults [clinicaltrials:NCT00054860]
Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults [clinicaltrials:NCT00054860]
Bio2RDF identifier
NCT00054860
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00054860
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... d cannot cause HIV infection.
brief title [clinicaltrials_vocabulary:brief-title]
Safety of and Immune System Re ...... 1090) in HIV Uninfected Adults
completion date [clinicaltrials_vocabulary:completion-date]
2005-09-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Epidemiological and ani ...... nancy tests during the study.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2003-02-11T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
AIDS Vaccines
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Dose-Response Relationship, Immunologic
HIV Preventive Vaccine
HIV Seronegativity
Vaccines, DNA
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-04-13T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00054860
official title [clinicaltrials_vocabulary:official-title]
A Phase I Dose-Escalation Clin ...... -Uninfected Adult Participants
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2015-04-01T00:00:00Z
identifier
clinicaltrials:NCT00054860
title
Safety of and Immune System Re ...... 1090) in HIV Uninfected Adults
@en
type
label
Safety of and Immune System Re ...... s [clinicaltrials:NCT00054860]
@en